NCT05593575: Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease |
|
|
| Recruiting | 2 | 320 | RoW | SPH3127+SPH3127matching placebo+valsartan matching placebo, SPH3127+valsartan matching placebo, SPH3127 matching placebo+valsartan | Shanghai Pharmaceuticals Holding Co., Ltd | Diabetic Kidney Disease | 06/25 | 06/25 | | |
NCT05948839: pBFS Guided rTMS Over DMPFC for Treatment-Resistant Depression |
|
|
| Recruiting | N/A | 170 | RoW | active rTMS treatment, sham rTMS treatment | Changping Laboratory, Hebei Mental Health Center, Shandong Daizhuang Hospital, West China Hospital, The Second Affiliated Hospital of Xinxiang Medical University | Treatment Resistant Depression, Major Depressive Disorder | 06/24 | 09/24 | | |